维普中文期刊产品整合服务
4篇 您的检索式:作者名="J.Labenz"
    题名 作者 年代 出处 被引量
1Helicobacter pylori and gastric cancer: current status of the Austrian-Czech-German gastric cancer prevention trial (PRISMA-Study)显示文摘AIM To test the hypothesis that Helicobacter pylori eradication alone can reduce the incidence of gastric cancer in a subgroup of individuals with an increased risk for this fatal disease.METHODS It is a prospective, randomized,double-blind, placebo-controlled multinational multicenter trial. Men between 55 and 65 years of age with a gastric cancer phenotype of Helicobacterpylori gastritis are randomized to receive a 7-day course of omeprazole 2 × 20 mg,clarithromycin 2 × 500 mg, and amoxicillin 2 ×lg for 7 days, or omeprazole2 × 20mg plusplacebo. Follow - up endoscopy is scheduled 3months after therapy, and thereafter in one-year intervals. Predefined study endpoints are gastric cancer, precancerous lesions (dysplasia, adenoma), other cancers, anddeath.RESULTS Since March 1998, 1524 target patients have been screened, 279 patients (18.3%) had a corpus-dominant type of H.pylori gastritis, and 167 of those were randomized (58.8%). In the active treatment group (n -- 86), H. pylori infection infection was cured in 88.9% of patients. Currently, thecumulative follow-up time is 3046 months (253.8patient-years, median follow-up 16 months). So far, none of the patients developed gastric cancer or any precancerous lesion. Three(1.8%) patients reached study endpoints other than gastric cancer.CONCLUSION Among men between 55 and 65years of age, the gastric cancer phenotype of H.pylori gastritis appears to be more common than expected. Further follow- up and continuing recruitment are necessary to fulfil the main aim of the study.S.Miehlke C.Kirsch B.Dragosics M.Gschwantler G.Oberhuber D.Antos P.Dite J.Lauter J.Labenz A.Leodolter P.Malfertheiner A.Neubauer G.Ehninger M.Stolte E.Bayerdorffer 2001World Journal of Gastroenterology2001,7,2:5
2Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative显示文摘M.Kulig A.Leodolter M.Vieth E.Schulte D.Jaspersen J.Labenz T.Lind W.Meyer‐Sabellek P.Malfertheiner M.Stolte S. N.Willich 2003Alimentary Pharmacology & Therapeutics2003,,8:1
3幽门螺旋菌感染的临床与诊断显示文摘早在100年前人们就观察到胃粘膜上有细菌生长,直到1983年Marshall等首次成功地对该菌进行了培养,即现在称为的幽门螺旋菌,从此开创了对该菌致病机制和临床意义的深入研究。幽门螺旋菌感染在世界上是最常见的感染性疾病之一,西方国家感染率随年龄增加而增加(每年增加1%)<。人是该菌的宿主,病原菌主要通过人人传播,污染的食物或饮水在感染环节中的意义尚不清楚。流行病学感染模式与甲型肝炎相似,卫生条件差的国家在儿童有很高的感染率。众所周知,亦可通过医疗器械,如经内窥镜及pH探条传染。J.Labenz G.Brsch 李明 1995德国医学1995,12,4:0
4幽门螺旋菌感染的治疗显示文摘近年来不断深化的研究,导致对消化性溃疡的全新认识。传统的“无酸就无溃疡”的观点应改为“无酸或无幽门螺旋菌就无溃疡”的新认识,95%的十二指肠溃疡及70%的胃溃疡应视为感染性疾病。幽门螺旋菌感染的治愈可致胃、十二指肠粘膜溃疡面的大部或全部修复,对治疗不敏感的病例也可加速病情痊愈或促进溃疡稳定恢复。幽门螺旋菌清除后。J.Labenz G.Brsch 彭小楚 1995德国医学1995,12,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费